Catalyst

Slingshot members are tracking this event:

Valeant (VRX) Announces Results from Second Phase 3 Trial Assessing IDP-118 Lotion for Plaque Psoriasis

Source Link:
http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-results-of-second-phase-3-study-for-psoriasis-treatment-idp-118-300388297.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
VRX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jan 10, 2017
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, Idp-118, Lotion, Plaque Psoriasis
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.